Date(s) - Nov 15, 2018 - Nov 16, 2018
9:00 am - 6:00 pm
Conference series takes pleasure in inviting the scientific community across the globe to attend the 9th Global Experts Meeting on Neuropharmacology during November 15-16, 2018 at Frankfurt, Germany with a motto of how drugs affect cellular function in the nervous system.
The gathering will address Pharmaceutical Research in the area of Pharmacology and Neuropharmacology, while laying emphasis on innovative methodologies in Clinical Neuropharmacology and Neurotechnology. Neuropharmacology 2018 will be the best venue for Neuropharmacology Students, Scientists, Neuropharmacology Researchers, Neuropharmacology Faculty, Medical Colleges, Neuropharmacology Associations and Societies, Business Entrepreneurs, Training Institutes, Software developing companies, Manufacturing Medical Devices Companies, Data Management Companies.
Harish C Pant, National Institutes of Health, USA; Istvan Berczi, University of Manitoba, Canada; Varghese John, University of California, USA; Joel B Schachter, Merck Research Laboratories, USA; Mariya Hristova, University College London, UK; James B Ames, University of California, USA; Teresa Duda, Salus University, USA; Stephanie C Joachim, University Eye Hospital, Germany; Jose F Abisambra, University of Kentucky, USA; Hari Shanker Sharma, Uppsala University, Sweden; Kazue Takayanagi, Seiwaen Geriatric Institute, Japan; Thomas Grund, University of Regensburg, Germany; Patrizia LoPresti, University of Illinois at Chicago, USA; Gjumrakch Aliev, GALLY International Biomedical Research Institute Inc., USA;
Neuropharmacology 2018 Conference will encourage Young Researcher’s Forum, scientists and the researchers in their early stage of career graph to widely discuss their outcome so as to enrich and develop the idea. The ‘Best Poster Award’ is meant to encourage students in taking active part in the International Science platform to sharpen their skills and knowledgebase.
The important tracks that are part of Neuropharmacology 2018 includes Neuroimmunology and Neuroinflammation, Clinical Neuropharmacology, Neurochemical Transmission, Molecular Neuropharmacology, Parkinson’s Disease, Alzheimer’s Disease and Dementia, Psychopharmacology, Behavioral and Addiction Neuropharmacology, Neural Stem Cell, Neuroethics, Neurotechnology and its Advances, Neuroendocrinology, Future Aspects of Neuropharmacology;
Neuropharmacology 2018 is comprised of 20 tracks and 90 sessions designed to offer comprehensive sessions that address current issue. For more scientific sessions and abstract submission, please visit: https://neuro.pharmaceuticalconferences.com/call-for-abstracts.php
The Abstracts that are accepted for presentations are published in the proceedings of the Journals like
Neurochemistry & Neuropharmacology: Open Access, Journal of Neurology & Neurophysiology and International Journal of Neurorehabilitation.
Grab the opportunity to participate by registering through flowing link:
Email us for any queries contact:
Geet Goyal | Program Manager
E: [email protected]